Atamestane

From Wikipedia, the free encyclopedia
Jump to: navigation, search
Atamestane
Atamestane.png
Systematic (IUPAC) name
(8R,9S,10S,13S,14S)-1,10,13-Trimethyl-7,8,9,11,12, 14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-dione
Clinical data
Legal status Class C (UK)
Identifiers
CAS number 96301-34-7 N
ATC code None
PubChem CID 57050
ChemSpider 51438 YesY
UNII 62GA3K28B6 YesY
ChEMBL CHEMBL2105987 N
Chemical data
Formula C20H26O2 
Mol. mass 298.419 g/mol
 N (what is this?)  (verify)

Atamestane is an aromatase inhibitor that is being studied in the treatment of cancer. Atamestane blocks the production of the hormone estrogen in the body.

It is selective.[1]

References[edit]

  1. ^ el Etreby MF (March 1993). "Atamestane: an aromatase inhibitor for the treatment of benign prostatic hyperplasia. A short review". J. Steroid Biochem. Mol. Biol. 44 (4-6): 565–72. doi:10.1016/0960-0760(93)90260-4. PMID 7682838. 

External links[edit]

  • Atamestane entry in the public domain NCI Dictionary of Cancer Terms


 This article incorporates public domain material from the U.S. National Cancer Institute document "Dictionary of Cancer Terms".